This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

BioProcess International Europe
Mark Your Calendar for BPI Europe 2023!
9-12 May 2023RAI in Amsterdam

Song Zhiwei, Pre-record
Senior Principal Scientist at A*STAR

Profile

Dr. Song Zhiwei obtained his Ph.D. degree in Biochemistry from the University of Michigan where he studied protein glycosylation in cancer cells and their interactions with plant lectins. His post-doc work was completed in the Biology Department at Massachusetts Institute of Technology (MIT) where he studied genetic control of apoptosis. He then worked at the Biotechnology Process Engineering Center (BPEC) at MIT, before moving to Singapore in 2002. Currently, Dr. Song is a Senior Principal Scientist at the Bioprocessing Technology Institute (BTI) of A*STAR. His lab has been focused on protein glycosylation, glycoengineering of CHO cells with different genome editing techniques, and production of antibodies with these glycosylation mutants for in vitro and in vivo characterizations.

Agenda Sessions

  • Improving the efficacy and productivity of recombinant biologics produced in CHO cells by genome editing

    10:15
  • Improving the efficacy and productivity of recombinant biologics produced in CHO cells by genome editing

    16:00